Board of Directors

Mark Evans - Chairman of Adeptio Pharmaceuticals Ltd

Mark P. Evans, Chairman and Chief Executive Officer

Over 25 years of experience in the pharmaceutical sector.

Early career pharmaceutical experience with Bencard, Allergan Limited and Adams Laboratories Inc.

Former Chief Executive Officer Cambridge Laboratories (Group) Limited.

Negotiated Over 50 strategic partnerships, development and distribution agreements throughout the EU, Australasia, USA and Canada.

As CEO of Cambridge Laboratories (Group) Limited developed all aspects of this privately held ethical Rx business, resulting in a value realization event and sale of assets which generated a $400 Million return for investors and commercial partners.

Handel Evans - Director of Adeptio Pharmaceuticals Ltd

Handel E. Evans, Director

Co-founder and former Executive Chairman of Pharmaceutical Marketing Services Inc and Walsh International Inc.

Co-founder and Senior Executive of IMS International Inc.

Former Board member of Allergan Inc.

Former Chairman of the British Urological Foundation.

Co-founder and Director Cambridge Laboratories (Group) Limited.

Henry Wendt - Director of Adeptio Pharmaceuticals Ltd

Henry Wendt III CBE, Director

Former Chairman of SmithKline Beecham Plc.

Founder and former Chairman of Global Health Care Partners, a unit of CSFB Private Equity.

Awarded Order of the Rising Sun with Gold and Silver Star by the Government of Japan in 1994 and Commander of the British Empire (CBE) in 1995.

Co-founder and Director Cambridge Laboratories (Group) Limited.